Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Monkeypox virus A35R protein is a transmembrane envelope glycoprotein expressed on the enveloped virion (EV) form of the virus, homologous to vaccinia virus A33R, and plays a critical role in poxvirus replication and pathogenesis. It facilitates the formation of actin-containing microvilli on infected cells, enabling efficient cell-to-cell spread of viral particles, and coordinates incorporation of other viral proteins into EV membranes as part of a complex with OPG162 and OPG190. Loss of A35R results in 1000-fold attenuation of viral virulence, underscoring its importance in infection. In monkeypox disease, A35R contributes to viral transmission and dissemination, making it a key player in orthopoxvirus infections like mpox outbreaks. Recent studies have identified high-affinity human monoclonal antibodies (e.g., EV35-2, EV35-6, EV35-7, mAb981) that bind a highly conserved epitope on A35R, blocking viral spread in vitro and protecting mice from lethal challenge via both Fc-dependent and independent mechanisms; elevated natural A35R-specific antibodies in convalescent sera correlate with better clinical outcomes. Crystal structures of A35R-antibody complexes reveal structural vulnerabilities exploitable for therapies, positioning A35R as a promising therapeutic target for next-generation orthopoxvirus treatments due to its conservation across poxviruses.
Neutralization of viral spread via binding to conserved epitope on A35R (Fc-dependent and Fc-independent), Blockade of enveloped virion transmission
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monkeypox virus A35R protein (A35R).